PharmaMar, Chugai terminate License Agreement for Zepsyre
PharmaMar announces that both Chugai and PharmaMar have entered into a mutual early termination agreement of this license agreement
Chugai Pharmaceutical Co., Ltd. ...
From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment
Continue readingAdvertisement
Advertisement
Advertisement
Advertisement
IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.